← FDA Drug Approvals (Drugs@FDA)

SLYND

NDA · New Drug Application · Sponsor: EXELTIS USA INC · Approved 2019-05-23

Drug application

FDA Application #

NDA211367

Application type

New Drug Application

Brand name

SLYND

Generic name

DROSPIRENONE

Active ingredients

DROSPIRENONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

EXELTIS USA INC

Manufacturer

Exeltis USA, Inc.

First approval

2019-05-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown